MedPath

Genetic Testing for Type 2 Diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Genetic: genetic testing for type 2 diabetes
Behavioral: Conventional risk counseling
Behavioral: eye disease counseling
Registration Number
NCT01060540
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

In this 6-month randomized, controlled trial, we examined whether providing participants with genetic test results and counseling regarding their risk for type 2 diabetes would motivate them to improve their health behaviors and lose weight to reduce their diabetes risk. We hypothesized that participants who received conventional diabetes counseling plus genetic test results and counseling would have at least 6 lb greater weight loss at 3 months than participants who received conventional diabetes counseling without genetic test results.

Detailed Description

In this 6-month randomized, controlled trial, we evaluated the impact of genetic testing for type 2 diabetes on psychological, health behavior, and clinical outcomes. Eligibility criteria included age 21 to 65 years, overweight or obese (body mass index \[BMI\] \>27 kg/m2), and no prior diagnosis of type 2 diabetes. At baseline, participants (N=601) had conventional risk factors assessed, including demographics, fasting plasma glucose (FPG), and family history. They also provided blood samples for genetic testing of TCF7L2, PPARG, and KCNJ11, three genes that confer elevated risk for development of type 2 diabetes. Participants were then randomized to receive conventional counseling plus control eye disease counseling (CR+EYE) or conventional counseling plus genetic test results (CR+G). Two to four weeks following the baseline visit, when the genetic test results were available, participants returned for a visit with a genetic counselor. All participants received conventional risk counseling based on their lifetime population risk, FPG results, and family history. Next, participants were informed of their randomization assignments; CR+EYE participants received counseling on eye diseases, whereas CR+G participants received genetic counseling. Then perceived risk, affect, self-efficacy, and readiness to change were assessed. All other outcomes were also assessed at 3 and 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
601
Inclusion Criteria
  • body mass index >27 kg/m2
  • baseline fasting plasma glucose <=125 mg/dL
Exclusion Criteria
  • prior diagnosis of type 2 diabetes
  • fasting plasma glucose >125 mg/dL on more than one occasion
  • HbA1c > 7%
  • taking diabetes medication
  • actively losing weight
  • enrolled in research study focusing on lifestyle changes
  • unable to provide informed consent or answer survey questions unassisted
  • residing in nursing home or receiving home health care
  • active diagnosis of psychosis or dementia
  • at least one error on 6-item cognitive screener

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CR+GConventional risk counselingconventional risk counseling (lifetime risk, fasting plasma glucose, and family history) plus genetic testing for type 2 diabetes
CR+Ggenetic testing for type 2 diabetesconventional risk counseling (lifetime risk, fasting plasma glucose, and family history) plus genetic testing for type 2 diabetes
CR+EYEeye disease counselingconventional risk counseling (lifetime risk, fasting plasma glucose, and family history) plus eye disease counseling
CR+EYEConventional risk counselingconventional risk counseling (lifetime risk, fasting plasma glucose, and family history) plus eye disease counseling
Primary Outcome Measures
NameTimeMethod
Weight3 months

weight 3 months post-enrollment

Secondary Outcome Measures
NameTimeMethod
Daily Caloric Intake3 months

Estimated daily caloric intake based on self-reported frequency and amount of intake of specific foods over the past 3 months as assessed by the Block Brief Food Frequency Questionnaire

Insulin Resistance (HOMA2-IR)3 months

Calculated using the updated homeostasis model assessment (HOMA) calculator at http://www.dtu.ox.ac.uk/homacalculator/

Higher numbers indicate higher insulin resistance. There are no established cutoffs indicating impaired resistance.

Moderate Intensity Physical Activity3 months

self-report based on the long version of the International Physical Activity Questionnaire. Moderate physical activity was queried in the domains of work (e.g., carrying light loads), transportation (e.g., bicycling), domestic chores and gardening (e.g., sweeping, raking), and leisure-time (e.g., bicycling, swimming).

Perceived Lifetime Risk of Type 2 Diabetes3 months

measured on 1-7 scale (definitely will not get diabetes to definitely will get diabetes)

Trial Locations

Locations (1)

Durham VA Medical Center, Durham, NC

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath